Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Structure of Lipids03:38

Structure of Lipids

Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming insulin receptor activation with a de novo agonist to overcome severe insulin resistance.

bioRxiv : the preprint server for biology·2026
Same author

Age-adjusted analysis of cVEMP frequency tuning using spline approximation for diagnosis of endolymphatic hydrops.

Acta oto-laryngologica·2026
Same author

Investigational treatments of β-cell failure and replacement.

Diabetology international·2026
Same author

Effect of Weight-Neutral Treatment With Semaglutide or Tirzepatide on β-Cell Identity in db/db Mice.

Acta physiologica (Oxford, England)·2025
Same author

Tuning insulin receptor signaling using de novo-designed agonists.

Molecular cell·2025
Same author

Fatty acid transport protein 2 inhibition enhances glucose tolerance through α cell-mediated GLP-1 secretion.

The Journal of clinical investigation·2025

Related Experiment Video

Updated: Jun 8, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

n-3 Fatty acids decrease arterial low-density lipoprotein cholesterol delivery and lipoprotein lipase levels in

Chuchun L Chang1, Toru Seo, Christine B Du

  • 1Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

Arteriosclerosis, Thrombosis, and Vascular Biology
|October 9, 2010
PubMed
Summary

Omega-3 fatty acids (n-3) reduce arterial cholesterol deposition in insulin-resistant mice. This effect is linked to decreased lipoprotein lipase (LpL) levels and altered distribution within the artery wall.

More Related Videos

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

Related Experiment Videos

Last Updated: Jun 8, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

Area of Science:

  • Cardiovascular Disease Research
  • Lipid Metabolism
  • Nutritional Science

Background:

  • Insulin resistance is a significant risk factor for cardiovascular disease.
  • Previous studies indicated saturated fats (SAT) increase arterial LDL cholesterol deposition, while n-3 fatty acids decrease it.
  • Arterial lipoprotein lipase (LpL) levels correlate with LDL cholesterol deposition.

Purpose of the Study:

  • To investigate the impact of n-3 fatty acids on arterial cholesterol delivery.
  • To determine the effect of n-3 fatty acids on lipoprotein lipase (LpL) levels in insulin-resistant mice.
  • To elucidate the relationship between n-3 fatty acids, arterial cholesterol, and LpL.

Main Methods:

  • Insulin receptor transgenic knockout mice (L1) were fed chow, SAT, or n-3 diets for 12 weeks.
  • Tracer studies using fluorescently labeled LDL and cholesteryl ester (CE) quantified LDL uptake and deposition.
  • Plasma lipids and arterial LpL distribution were analyzed.

Main Results:

  • n-3 diets significantly reduced plasma lipids and ameliorated insulin resistance compared to SAT diets.
  • n-3 diets markedly decreased arterial LDL uptake, CE deposition, and selective uptake.
  • SAT diets increased LpL throughout the aortic media, whereas n-3 diets localized LpL to the intima.

Conclusions:

  • n-3 fatty acids effectively diminish arterial LDL-cholesterol deposition in mice with insulin resistance.
  • The observed reduction in cholesterol deposition is associated with altered arterial LpL levels and distribution.
  • These findings highlight a potential therapeutic role for n-3 fatty acids in managing cardiovascular risk associated with insulin resistance.